IMMUNOGLOBULIN G1 (251-GLUTAMINE,298-ALANINE,429-LEUCINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL F520 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL F520 .KAPPA.-CHAIN, DIMER
Hepatocellular Carcinoma
Shandong New Time Pharmaceutical Co., LTDmonoclonal_antibodyPhase 2/3Active
CCC
50/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 65/ 100
Competitive context
520 Active assets in the Hepatocellular Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Adefovir Bukwang Pharmaceutical | Phase 4 | BBB |
Huaier Granule Tongji Hospital | Phase 4 | BBB |
Sorafenib Bayer | Phase 4 | BBB |
Carboplatin AstraZeneca | Phase 4 | BB |
Theprubicin RWTH Aachen University | Phase 4 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →